This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Manitoba directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $180,000
Best Effective Antibiotic Treatment for Community Acquired Pneumonia (BEAT-CAP): A pilot feasibility domain of the GUARD-Resp platform trial
CIHR · 2025 · Co-investigator
- $1,375,000
Dexamethasone For Preventing Deterioration In Community Acquired Pneumonia (DEFEND-CAP)
CIHR · 2023 · Principal investigator
- $5,500,001
Dexamethasone For Preventing Deterioration In Community Acquired Pneumonia (DEFEND-CAP)
CIHR · 2023 · Principal investigator
Best Effective Antibiotic Treatment for Community Acquired Pneumonia (BEAT-CAP): A pilot feasibility domain of the GUARD-Resp platform trial
Principal investigators: Lother, Sylvain
Keywords: Antibiotic; Pneumonia
Dexamethasone For Preventing Deterioration In Community Acquired Pneumonia (DEFEND-CAP)
Principal investigators: Zarychanski, Ryan; Lawler, Patrick R; Lother, Sylvain; McDonald, Emily G
Keywords: Bayesian Adaptive Trial; Community Acquired Pneumonia (Cap); Corticosteroids; Dexamethasone; Phase Iii Trial; Randomized Trial
Dexamethasone For Preventing Deterioration In Community Acquired Pneumonia (DEFEND-CAP)
Principal investigators: Zarychanski, Ryan; Lawler, Patrick R; Lother, Sylvain; McDonald, Emily G
Keywords: Bayesian Adaptive Trial; Community Acquired Pneumonia (Cap); Corticosteroids; Dexamethasone; Phase Iii Trial; Randomized Trial
Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP)
Principal investigators: Zarychanski, Ryan; Lawler, Patrick R; Turgeon, Alexis F
Keywords: Community Acquired Pneumonia; Heparin; Randomized Trial; Therapeutic Anticoagulation
ANTI-THROMBOTIC THERAPY TO AMELIORATE COMPLICATIONS OF COVID-19 (ATTACC): A randomized, international, multi-centre, adaptive, controlled clinical trial
Principal investigators: Zarychanski, Ryan; Escobedo, Jorge; Goligher, Ewan C; Lawler, Patrick R; Nicolau, Jose C
Keywords: Anti-Thrombotic; Bayesian Adaptive; Covid-19; Sepsis; Thrombosis
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.